Resources

Intelligent Drug Screening

Material and information relating to our Intelligent Drug Screening solution. If you have a specific request, please contact us.

White Paper

Customer Case Studies

Image Gallery

A5 Product Flyer

A4 Product Flyer

Frequently Asked Questions

Sweat testing can detect a wide range of drugs, including cannabis (THC), cocaine, methamphetamines, opiates, and more. The specific drugs detectable depend on the testing panel on the cartridge.

A small, tamper-evident drug screening cartridge quickly collects ten fingerprint sweat samples, which are then analyzed in our DSR-Plus reader for precise on-screen results in minutes. Find out more here.

Our drug screening device tests for “fitness for duty” on the day and has a detection window of 16-24 hours. The detection window for drugs in sweat can vary depending on factors such as the drug’s half-life, the individual’s metabolism, and the specific testing method.

Sweat drug screening is considered highly accurate and has comparable performance characteristics to saliva and urine. 

External factors, such as temperature, humidity, and physical activity, can influence sweat production. However, our screening method is designed to account for these variables and ensure accurate results.

Yes, sweat screening is suitable for post-accident and reasonable suspicion testing, as it can provide insights into recent drug use within the defined detection window.

Sample collection takes <1 min. Results are displayed in up to 10 minutes if you are conducting a single test as it takes approximately this long for the chemical reaction to take place once the sweat samples are collected.

However, there is a batch test functionality that can reduce the time per test to <3 min.

Comprehensive training of application and collection of specimens is delivered by Intelligent Bio Solutions. Virtual and in person delivery options are available. The training and certification for collection of specimens by sweat will allow nominated personnel to administer sweat drug screening for your organization.

2 years from the date of manufacture.

Yes, non-negative screening test results may be verified using our back-to-lab confirmation service, provided by an independent, accredited laboratory. Our fingerprint collection kit for laboratory analysis is used to collect and return two sets of fingerprint samples for laboratory testing.

Testing and record keeping processes comply with applicable privacy legislation. All drug testing is performed in an area appropriate for the testing type to ensure the outcome is only known to the person and authorised tester, and not those waiting to be tested.

Results from laboratory confirmation are emailed directly by our partner laboratory to the nominated contact at your organisation with a unique password to download the results.

Yes, we offer in person and virtual demonstrations. Complete the form on this page to request a demonstration.

Latest Drug Screening News

INBS Successfully Manufactures First Readers with New Partner 2

Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry

NEW YORK, February 25, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful receipt and deployment of the first shipment of Intelligent Fingerprinting Drug Screening Readers manufactured under its new strategic manufacturing partnership with Syrma Johari MedTech Ltd. (“Syrma…

READ MORE >
Bouygues UK

Intelligent Bio Solutions Partners with Bouygues UK, Part of Multi-Billion Dollar Global Construction Giant Bouygues Construction, for UK Drug Testing Rollout

NEW YORK, February 24, 2026 -Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced a partnership with Bouygues UK, a subsidiary of Bouygues Construction, a multi-billion-dollar global construction firm with 35,600 employees, for the deployment of INBS’s fingerprint drug screening technology across…

READ MORE >
Clinical Studies

Intelligent Bio Solutions Initiates Additional Clinical Studies for FDA 510(k) Submission Supporting Planned Entry into Multi-Billion Dollar U.S. Market

NEW YORK, January 28, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the commencement of its clinical study program to support its new FDA 510(k) submission for U.S. market clearance of its Intelligent Fingerprinting Drug Screening System for detection of the opiate…

READ MORE >

Sign Up

Subscribe to receive the latest news and updates from Intelligent Bio Solutions.

Request a Fingerprint Drug Test Demonstration

Non-invasive, cost-effective, and efficient workplace drug testing

Learn how our Intelligent Fingerprinting Drug Test can work for your business.

Book a no-obligation online or in-person demonstration today.